Iron Infusions and Delayed Burning Sensations in Extremities

Introduction to Delayed Reactions

Iron infusions can cause delayed burning sensations in the feet and hands, which are documented as part of delayed hypersensitivity reactions to intravenous iron preparations, according to the American Journal of Kidney Diseases 1, 2

Intravenous iron can cause both immediate and delayed adverse reactions, with delayed reactions characterized by symptoms including arthralgias, myalgias, and potentially burning sensations in extremities, as reported by the American Journal of Hematology and the American Journal of Kidney Diseases 3, 2
The mechanism is likely related to complement activation-related pseudo-allergy (CARPA) triggered by iron nanoparticles rather than true IgE-mediated allergic reactions, according to the American Journal of Hematology 3

Delayed reactions to IV iron dextran, characterized by arthralgias and myalgias (which can manifest as burning sensations), are dose-related and occur in up to 59% of patients receiving total dose infusions, as documented by the American Journal of Kidney Diseases 1, 2

Higher doses of iron (particularly with total dose infusions) significantly increase the risk of delayed reactions, according to the American Journal of Kidney Diseases 1, 2
Faster infusion rates are associated with higher risk of both immediate and delayed reactions, as reported by the American Journal of Hematology 3
Previous reactions to iron infusions increase the likelihood of subsequent reactions, according to the American Journal of Hematology and other sources 3, 5

NSAIDs are the first-line treatment for delayed reactions including burning sensations in extremities, as recommended by the American Journal of Hematology and other sources 3, 5
For more severe symptoms, corticosteroids may be considered, according to the American Journal of Hematology and other sources 3, 5

Use slower infusion rates, especially for patients with previous reactions, as suggested by the American Journal of Hematology and other sources 3, 5
Monitor patients for at least 15 minutes after infusion and educate them about potential delayed reactions, as recommended by the American Journal of Hematology 3
Ensure patients understand to report delayed symptoms like burning sensations in extremities, as these may indicate a reaction requiring medical attention, according to the American Journal of Hematology and other sources 3, 5